Ignite Creation Date:
2025-12-24 @ 3:01 PM
Ignite Modification Date:
2025-12-29 @ 10:45 PM
Study NCT ID:
NCT02609659
Status:
COMPLETED
Last Update Posted:
2019-12-10
First Post:
2015-11-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10-28
Start Date Type:
ACTUAL
Primary Completion Date:
2016-10-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-18
First Submit QC Date:
None
Study First Post Date:
2015-11-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-09-21
Results First Submit QC Date:
None
Results First Post Date:
2017-10-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-27
Last Update Post Date:
2019-12-10
Last Update Post Date Type:
ACTUAL